Default company panoramic image


An implantable insulin dispenser frees diabetics from daily self testing, automatically infusing insulin. Physical activity no problem.

  • Stage Concept Only
  • Industry Biotechnology
  • Location Los Angeles, CA, USA
  • Currency USD

Company Summary

Diabetes is one of the major areas of concern worldwide. Currently, over 275 million people suffer from diabetes. This is expected to exceed 350 million by 2030. The Global Market for diabetes drugs and devices is expected to attain a market size of $114.3 billion by 2016. Cellexir is engaged in development and marketing a unique approach that will allow naturally produced insulin to be auitomatically dispensed. No selftesting needed.


  • Default avatar
    Michael Piliavin

    Dr. Piliavin has been engaged in the development of medical devices, electro-optics and scientific algorithms for over 20 years.